One big unhappy family: Transfusion alloimmunization, thrombosis, and immune modulation/inflammation

Transfusion

Volumn 49, Issue 6, 2009, Pages 1032-1036

  Joanna, M Heal ^b   Phipps, R P ^a   Blumberg, N ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CD40 LIGAND; ERYTHROCYTE ANTIBODY;

ALLOIMMUNIZATION; APHERESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILL; DRUG ACTIVITY; EDITORIAL; ERYTHROCYTE TRANSFUSION; FEVER; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; RIGOR; SIDE EFFECT; TH1 CELL; TH2 CELL; THROMBOCYTE TRANSFUSION; THROMBOSIS; TRANSFUSION RELATED ACUTE LUNG INJURY;

ABO BLOOD-GROUP SYSTEM; ERYTHROCYTES; FEVER; HUMANS; INFLAMMATION; PLATELET TRANSFUSION; RH ISOIMMUNIZATION; TH1 CELLS; TH2 CELLS; THROMBOSIS;

EID: 66549094237     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02182.x     Document Type: Editorial

References (45)

1. Yazer MH, Triulzi DJ, Shaz B, Kraus T, Zimring JC. Does a febrile reaction to platelets predispose recipients to red cell alloimmunization? Transfusion 2009 49 : 1070 5.
2. Hendrickson JE, Chadwick TE, Roback JD, Hillyer CD, Zimring JC. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 2007 110 : 2736 43.
3. Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, Zimring JC. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006 46 : 1526 36.
4. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001 357 : 2023 4.
5. Blumberg N, Gettings KF, Turner C, Heal JM, Phipps RP. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006 46 : 1813 21.
6. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006 108 : 2455 62.
7. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Chavarin P, Cogné M, Richard Y, Garraud O. Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. Exp Hematol 2007 35 : 1376 87.
8. Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 2008 111 : 5028 36.
9. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986 136 : 2348 57.
10. Coffman RL. Origins of the T(H)1-T(H)2 model: a personal perspective. Nat Immunol 2006 7 : 539 41.
11. McGuirk P, Mills KH. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 2002 23 : 450 5.
12. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997 389 : 737 42.
13. Wang YH, Liu YJ. The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol 2008 20 : 697 702.
14. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000 164 : 6166 73.
15. Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood 2008 112 : 1557 69.
16. Blumberg N, Heal JM. The transfusion immunomodulation theory: the Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism. Semin Hematol 1996 33 : 329 40.
17. Sprague DL, Sowa JM, Elzey BD, Ratliff TL. The role of platelet CD154 in the modulation in adaptive immunity. Immunol Res 2007 39 : 185 93.
18. Babcock GF, Alexander JW. The effects of blood transfusion on cytokine production by TH1 and TH2 lymphocytes in the mouse. Transplantation 1996 61 : 465 8.
19. Kirkley SA, Cowles J, Pellegrini VD Jr., Harris CM, Boyd AD, Blumberg N. Cytokine secretion after allogeneic or autologous blood transfusion. Lancet 1995 345 : 527.
20. Kirkley SA, Cowles J, Pellegrini VD Jr., Harris CM, Boyd AD, Blumberg N. Blood transfusion and total joint replacement surgery: T helper 2(Th2) cytokine secretion and clinical outcome. Transfus Med 1998 8 : 195 204. (Pubitemid 28436923)
21. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 2005 45 : 33S 9S discussion 9S-40S.
22. Wadhwa M, Krailadsiri P, Dilger P, Gaines Das R, Seghatchian MJ, Thorpe R. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates. Vox Sang 2002 83 : 125 36.
23. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995 35 : 117 24.
24. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003 23 : 2131 7.
25. Lee SP, Ataga KI, Orringer EP, Phillips DR, Parise LV. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation. Arterioscler Thromb Vasc Biol 2006 26 : 1626 31.
26. Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008 168 : 2377 81.
27. Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP. The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res 2009 Jan 29. [Epub ahead of print].
28. Xu H, Yan J, Huang Y, Chilton PM, Ding C, Schanie CL, Wang L, Ildstad ST. Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization. Blood 2008 111 : 3266 75.
29. Blumberg N, Heal JM, Liesveld JL, Phillips GL, Rowe JM. Platelet transfusion and survival in adults with acute leukemia. Leukemia 2008 22 : 631 5.
30. Perkins JD. Platelet transfusions have a negative impact on liver transplant survival. Liver Transpl 2008 14 : 701 2.
31. Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, Murkin J, Nadel A. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004 44 : 1143 8.
32. Kenton AB, Hegemier S, Smith EO, O'Donovan DJ, Brandt ML, Cass DL, Helmrath MA, Washburn K, Weihe EK, Fernandes CJ. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity. J Perinatol 2005 25 : 173 7.
33. Dineen SP, Roland CL, Toombs JE, Kelher M, Silliman CC, Brekken RA, Barnett CC Jr. The acellular fraction of stored platelets promotes tumor cell invasion. J Surg Res 2008 May 7. [Epub ahead of print].
34. Aiboshi J, Moore EE, Ciesla CJ, Silliman CC. Blood transfusion and the two-insult model of post-injury multiple organ failure. Shock 2001 15 : 302 6.
35. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005 105 : 2266 73.
36. Blumberg N, Heal JM, Gettings KF. WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion 2003 43 : 945 52.
37. Campbell-Lee SA, Liu J, Ness PM, Baldwin WM. Red blood cell alloimmunization is affected by depletion of donor white cell subsets. ASH Annual Meeting Abstracts. Blood 2007 110 : 456.
38. Carr R, Hutton JL, Jenkins JA, Lucas GF, Amphlett NW. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 1990 75 : 408 13.
39. Heal JM, Masel D, Rowe JM, Blumberg N. Circulating immune complexes involving the ABO system after platelet transfusion. Br J Haematol 1993 85 : 566 72.
40. Berger S, Chandra R, Ballo H, Hildenbrand R, Stutte HJ. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur J Immunol 1997 27 : 2994 3000. (Pubitemid 27478373)
41. Ryan EP, Malboeuf CM, Bernard M, Rose RC, Phipps RP. Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particles. J Immunol 2006 177 : 7811 9.
42. Ryan EP, Pollock SJ, Murant TI, Bernstein SH, Felgar RE, Phipps RP. Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J Immunol 2005 174 : 2619 26.
43. Pitchford SC. Novel uses for anti-platelet agents as anti-inflammatory drugs. Br J Pharmacol 2007 152 : 987 1002. (Pubitemid 350166038)
44. Lawler SD, Fisher RA. Immunogenicity of hydatidiform mole. Placenta 1987 8 : 195 9.
45. Brynger H, Rydberg L, Samuelsson B, Sandberg L. Experience with 14 renal transplants with kidneys from blood group A (subgroup A2) to O recipients. Transplant Proc 1984 16 : 1175 6.